Effect of vehicles and enhancers on the topical delivery of cyclosporin A

International Journal of Pharmaceutics

Volumn 311, Issue 1-2, 2006, Pages 182-186

  Liu, Hongzhuo ^a   Li, Sanming ^a   Wang, Yongjun ^a   Yao, Huimin ^a   Zhang, Yan ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Cyclosporin A; Enhancer; Pre treatment; Topical; Vehicle

Indexed keywords

ALCOHOL; CYCLOSPORIN A; DIETHYLENE GLYCOL MONOETHYL ETHER; DODECYL SULFATE SODIUM; DRUG VEHICLE; ETHYL OLEIC ACID; LABRASOL; LAUROCAPRAM; LAUROGLYCOL; MENTHOL; MYRISTIC ACID ISOPROPYL ESTER; N METHYLPYRROLIDONE; PROPYLENE GLYCOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ULTRAVIOLET RADIATION;

ADMINISTRATION, TOPICAL; ANIMALS; CYCLOSPORINE; DIFFUSION CHAMBERS, CULTURE; DRUG DELIVERY SYSTEMS; ETHANOL; ETHYLENE GLYCOLS; MALE; MENTHOL; OLEIC ACIDS; PERMEABILITY; RATS; SKIN; SODIUM DODECYL SULFATE; SOLVENTS; SURFACE-ACTIVE AGENTS; TIME FACTORS; VEHICLES;

EID: 33644613443     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2005.12.029     Document Type: Article

References (35)

1. A.N.C. Anigbogu, A.C. Williams, and B.W. Barry Permeation characteristics of 8-methoxypsoralen through human skin: relevancen in clinical treatment J. Pharm. Pharmacol. 48 1996 357 366
2. B.W. Barry Lipid-protein-partitioning theory of skin penetration enhancement J. Control. Release 15 1991 237 248
3. B.W. Barry Novel mechanisms and devices to enable sucessful transdermal drug delivery Eur. J. Pharm. Sci. 14 2001 102 114
4. B.W. Barry Beaching the skin's barrier to drugs Nat. Biotechnol. 22 2004 165 167
5. R.R. Boinpally, S.-Li Zhou, G. Devraj, P.K. Anne, S. Poondru, and B.R. Jasti Iontophoresis of lecithin vesicles of Cyclosporin A Int. J. Pharm. 274 2004 185 190
6. J. Borrás-Blasco, A. López, M.J. Morant, O. Diez-Sales, and M. Herráez-Domínguez Influence of sodium lauryl sulphate on the in vitro percutaneous absorption of compounds with different lipophilicity Eur. J. Pharm. Sci. 5 1997 15 22
7. H.K. Choi, and G.L. Flynn Percutaneous absorption and dermal delivery of Cyclosporin A J. Pharm. Sci. 84 1995 581 583
8. P.A. Cornwell, B.W. Barry, J.A. Bouwstra, and G.S. Goods Modes of action of terpene penetration enhancers in human skin: differential scanning calorimetry, small angle X-ray diffraction and enhancer uptake studies Int. J. Pharm. 127 1996 9 26
9. J.I. Duncan, S.N. Payne, A.J. Winfield, A.D. Ormerod, and A.W. Thomson Enhanced percutaneous absorption of a novel topical Cyclosporin A formulation and assessment of its immunosuppressive activity Br. J. Dermatol. 123 1990 631 640
10. J. Guo, Q.G. Ping, and C. Jiao Lecithin vesicular carriers for transdermal delivery of Cyclosporin A Int. J. Pharm. 194 2000 201 207
11. J.X. Guo, Q.N. Ping, T. Wu, and X.F. Hu Pharmacokinetic of behaviors transdermal delivery and oral administration of Cyclosporin A preparations in mice J. China Pharm. Univ. 31 2000 340 343
12. C. Guzzo Recent advances in the treatmet of psoriasis Dermatol. Clin. 15 1997 59 68
13. T. Hultsch, A. Kapp, and J. Spergel Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis Dermatology 211 2005 174 187
14. R. Kadir, D. Stempler, Z. Liron, and S. Cochen Delivery of theophlline into excised human skin from alkanoic acid solution: a "push-pull" mechanism J. Pharm. Sci. 76 1987 774 779
15. L. Kikwai, N. Kanikkannan, R.J. Babu, and M. Singh Effect of vehicles on the transdermal delivery of melatonin across porcine skin in vitro J. Control. Release 83 2002 307 311
16. C.K. Kim, J.J. Kim, S.C. Chi, and C.K. Shim Effect of fatty acids and urea on the penetration of ketoprofen through rat skin Int. J. Pharm. 99 1993 109 118
17. D. Kobayashi, T. Matsuzawa, Y. Sugibayashi, Morimoto, and M. Kimura Analysis of the combined effect of 1-menthol and ethanol as skin permeation enhancers based on a two-layer skin model Pharm. Res. 11 1994 96 103
18. L.B. Lopes, J.H. Collett, and M.V.L.B. Bentley Topical delivery of Cyclosporin A: an in vitro study using monoolein as a penetration enhancer Eur. J. Pharm. Biopharm. 60 2005 25 30
19. K. Moster, K. Kriwet, A. Naik, Y.N. Kalia, and R.H. Guy Passive skin penetration enhancement and its quantification in vitro Eur. J. Pharm. Biopharm. 52 2001 103 112
20. R. Panchagnula, P.S. Salve, N.S. Thomas, A.K. Jain, and P. Ramarao Transdermal delivery of naloxane: effect of water, propylene glycol, ethanol and their binary combinations on permeation through rat skin Int. J. Pharm. 219 2001 95 105
21. A. Parodi, R. Gallo, M. Grarrera, and A. Rebora Natural alpha interferon in chronic actinic dermatitis: report of a case Ada. Derm. Venereol. 75 1995 80
22. L. Pershing, L. Lambert, and K. Knutson Mechanism of ethanol-enhanced estradiol permeation across human skin in vivo Pharm. Res. 7 1990 170 175
23. O. Pillai, V. Nair, and R. Panchagnula Transdermal ionphoresis of insulin: IV. Influence of chemical enhancer Int. J. Pharm. 269 2004 109 120
24. C.H. Ribaud, J.C. Garson, J. Doucet, and J.L. Leveque Oranization of strarum corneum lipids in relation to permability: influence of sodium lauryl sulfate and preheating Pharm. Res. 11 1994 1414 1418
25. W.A. Ritschel, R. Panchagnula, K. Stemmer, and M. Ashraf Development of an intracutaneous depot for drugs: binding, drug accumulation and retention studies, and mechanism of depot Skin Pharmacol. 4 1991 235 245
26. H.H. Roenigkjk, and H.I. Maibach Psoriasis 1998 Marcel Dekker Inc. New York
27. D.M. Small Lateral chain packing in lipids and membrane J. Lipid Res. 76 1984 1494 1500
28. H.S. Tran, D. Malli, F.V. Chrzanowski, M.M. Puc, M.S. Matthews, and C.W. Hewitt Site-specific immunosuppression using a new formulation of topical Cyclosporin A with polyethylene glycol-8 glyceryl caprylate/caprate J. Surg. Res. 83 1999 136 140
29. D.D. Verma, and A. Fahr Synergistic penetration enhancement effect of ethanol and phosphoilipids on the topical delivery of Cyclosporin A J. Control. Release 97 2004 55 66
30. D.D. Verma, S. Verma, K.J. McElwee, P.P. Freyschmidt, R. Hoffman, and A. Fahr Treatment of alopecia areata in the DEBR model using Cyclosporin A lipid vesicles Eur. J. Dermatol. 14 2004 332 338
31. Vc, and Ho The use of cyclosporin in psoriasis: a clinical review Br. J. Dermatol. 150 2004 1 10
32. S. Wang, M. Kara, and T.R. Krishnan Transdermal delivery of Cyclosporin A using electroporation J. Control. Release 50 1998 61 70
33. A.C. Williams, and B.W. Barry Skin absorption enhancers Crit. Rev. Ther. Drug Carrier Syst. 9 1992 305 353
34. A.C. Williams, and B.W. Barry Penetration enhancers Adv. Drug Deliv. Rev. 56 2004 603 618
35. H. Zachariae, K. Kragballe, and H. Hansen Renal biopsy findings in long-term cyclosporin treatment of psoriasis Br. J. Dermatol. 136 1997 531 535